0001950047-24-001668.txt : 20240301 0001950047-24-001668.hdr.sgml : 20240301 20240301163226 ACCESSION NUMBER: 0001950047-24-001668 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 24710487 BUSINESS ADDRESS: STREET 1: 1150 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (925) 407-1049 MAIL ADDRESS: STREET 1: 1150 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Brandenberger Ralph CENTRAL INDEX KEY: 0001853197 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 102 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001853197 XXXXXXXX LIVE 0001787400 NKARTA INC 001-39370 1150 Veterans Boulevard South San Francisco CA 94080 4155824923 RALPH ERIK BRANDENBERGER Officer COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

8367 101073.36 49072342 03/01/2024 NASDAQ Common 03/01/2024 Exercise of Stock Options Issuer N 6763 03/01/2024 Cash Common 01/14/2023 Restricted Stock Units Issuer N 1604 01/14/2023 N/A Y The securities to be sold were acquired upon the exercise of stock options and the vesting of restricted stock units from 1/14/2023 through 1/14/2024. 03/01/2024 09/02/2022 /s/ Ralph Erik Brandenberger